X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (996) 996
Book Review (300) 300
Publication (27) 27
Conference Proceeding (5) 5
Book Chapter (3) 3
Magazine Article (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (954) 954
index medicus (911) 911
anti-dyskinesia agents - therapeutic use (903) 903
botulinum toxins - therapeutic use (663) 663
female (465) 465
male (459) 459
clinical neurology (341) 341
middle aged (319) 319
adult (294) 294
botulinum toxin (284) 284
treatment outcome (258) 258
aged (224) 224
neurosciences (179) 179
anti-dyskinesia agents - administration & dosage (177) 177
botulinum toxins - administration & dosage (135) 135
double-blind (134) 134
dystonia (119) 119
child (117) 117
anti-dyskinesia agents - adverse effects (108) 108
animals (99) 99
adolescent (95) 95
anti-dyskinesia agents - pharmacology (94) 94
cervical dystonia (94) 94
abridged index medicus (93) 93
psychiatry (90) 90
neurology (86) 86
surgery (84) 84
injections (82) 82
dystonia - drug therapy (81) 81
muscle spasticity - drug therapy (78) 78
botulinum toxins - adverse effects (73) 73
electromyography (72) 72
botulinum toxins - pharmacology (70) 70
haloperidol - therapeutic use (70) 70
pharmacology & pharmacy (70) 70
follow-up studies (69) 69
botulinum toxins, type a - therapeutic use (67) 67
aged, 80 and over (66) 66
retrospective studies (66) 66
care and treatment (63) 63
pediatrics (63) 63
spasticity (63) 63
injections, intramuscular (62) 62
medicine & public health (62) 62
severity of illness index (62) 62
time factors (62) 62
child, preschool (61) 61
efficacy (61) 61
gastroenterology & hepatology (61) 61
torticollis - drug therapy (59) 59
management (57) 57
children (55) 55
magnetic resonance imaging (54) 54
rehabilitation (51) 51
therapy (48) 48
dyskinesia, drug-induced - drug therapy (47) 47
injection (47) 47
medicine, general & internal (47) 47
prospective studies (47) 47
placebo-controlled trial (44) 44
safety (44) 44
a toxin (42) 42
blepharospasm - drug therapy (42) 42
dose-response relationship, drug (42) 42
drug therapy (40) 40
ophthalmology (40) 40
spasmodic torticollis (40) 40
achalasia (39) 39
chorea - drug therapy (39) 39
movement disorders (38) 38
otorhinolaryngology (38) 38
esophageal achalasia - therapy (37) 37
hemifacial spasm (37) 37
diagnosis (36) 36
infant (36) 36
movement disorders - drug therapy (36) 36
muscle spasticity - etiology (36) 36
antipsychotic agents - adverse effects (34) 34
blepharospasm (34) 34
dystonic disorders - drug therapy (34) 34
tetrabenazine - therapeutic use (34) 34
cerebral palsy - drug therapy (33) 33
trial (33) 33
health aspects (32) 32
hemifacial spasm - drug therapy (32) 32
pain (32) 32
research (32) 32
diagnosis, differential (31) 31
parkinson's disease (31) 31
parkinsons-disease (31) 31
cerebral-palsy (30) 30
movement-disorders (30) 30
quality of life (30) 30
randomized controlled trials as topic (30) 30
cerebral palsy (29) 29
stroke (29) 29
antipsychotic agents - therapeutic use (28) 28
chorea - etiology (28) 28
chronic disease (28) 28
dyskinesias - drug therapy (28) 28
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (882) 882
French (33) 33
Spanish (17) 17
German (16) 16
Japanese (11) 11
Portuguese (10) 10
Russian (8) 8
Finnish (4) 4
Polish (4) 4
Hebrew (3) 3
Dutch (2) 2
Bosnian (1) 1
Hungarian (1) 1
Italian (1) 1
Norwegian (1) 1
Romanian (1) 1
Serbian (1) 1
Slovak (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal Article
The Lancet, ISSN 0140-6736, 03/2019, Volume 393, Issue 10175, pp. 1033 - 1033
Journal Article
Journal Article
European Journal of Neurology, ISSN 1351-5101, 07/2010, Volume 17, Issue 1, pp. 28 - 30
Spasmodic dysphonia is a focal laryngeal dystonia, with adductor, abductor, mixed, respiratory and singer's types. Our series over 24 years includes 1300... 
MANAGEMENT | LARYNGEAL NERVE RESECTION | SPASTIC DYSPHONIA | DYSTONIA | CRUSH | NEUROSCIENCES | SECTION | CLINICAL NEUROLOGY | Anti-Dyskinesia Agents - therapeutic use | Botulinum Toxins - therapeutic use | Dysphonia - drug therapy | Electromyography | Injections, Intramuscular | Humans | Index Medicus
Journal Article
Journal Article
Psychopharmacology, ISSN 0033-3158, 10/2006, Volume 188, Issue 3, pp. 281 - 292
This double-blind, placebo-controlled study investigated the efficacy and safety of intramuscular (IM) aripiprazole and IM haloperidol for the treatment of... 
Intramuscular antipsychotic therapy | Acute agitation | Efficacy | Intramuscular aripiprazole | Safety | Intramuscular haloperidol | intramuscular aripiprazole | MANAGEMENT | PSYCHIATRY | NEUROSCIENCES | acute agitation | efficacy | ATYPICAL ANTIPSYCHOTICS | RELAPSE | safety | intramuscular antipsychotic therapy | PHARMACOLOGY & PHARMACY | OLANZAPINE | SHORT-TERM | ZIPRASIDONE | Piperazines - administration & dosage | Psychotic Disorders - complications | Antipsychotic Agents - adverse effects | Humans | Haloperidol - administration & dosage | Male | Schizophrenia - complications | Withholding Treatment - statistics & numerical data | Aripiprazole | Psychomotor Agitation - drug therapy | Quinolones - adverse effects | Time Factors | Antipsychotic Agents - therapeutic use | Quinolones - therapeutic use | Adult | Female | Anti-Dyskinesia Agents - administration & dosage | Drug Therapy, Combination | Basal Ganglia Diseases - chemically induced | Acute Disease | Double-Blind Method | Administration, Oral | Haloperidol - therapeutic use | Treatment Outcome | Piperazines - therapeutic use | Injections, Intramuscular | Haloperidol - adverse effects | Piperazines - adverse effects | Antipsychotic Agents - administration & dosage | Anti-Dyskinesia Agents - therapeutic use | Quinolones - administration & dosage | Anti-Dyskinesia Agents - adverse effects | Adolescent | Psychomotor Agitation - complications | Benzodiazepines - administration & dosage | Benzodiazepines - adverse effects | Psychotic Disorders - drug therapy | Schizophrenia - drug therapy | Blood Glucose - metabolism | Benzodiazepines - therapeutic use | Schizophrenia | Clinical trials | Comparative studies | Side effects | Pharmacology | Muscular system | Index Medicus
Journal Article